ELITE PHARMACEUTIC COM USD0.01 (ELTP)

0.12
0.00 0.42
OTC
Prev Close 0.12
Open 0.12
Day Low/High 0.12 / 0.12
52 Wk Low/High 0.10 / 0.25
Volume 408.87K
Exchange OTC
Shares Outstanding 775.55B
Market Cap 90.74M
Div & Yield N.A. (N.A)

Latest News

Elite Pharmaceuticals, Inc. Reports Financial Results For The Fiscal Year Ended March 31, 2017 And Provides Conference Call Information

Conference Call Scheduled for Thursday, June 15 at 2:00 PM EDT

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss Financial Results On June 15, 2017

Financials for Fiscal Year Ended March 31, 2017 will be released on June 14, 2017

Elite Pharmaceuticals Acquires Trimipramine ANDA

Dr. Reddy's Laboratories to Provide Marketing and Sales

Elite Pharmaceuticals, Inc. Reports Results For Third Quarter Of Fiscal Year 2017

Conference Call Scheduled for Monday, February 13 at 11:30 AM EST

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss 3rd Quarter 2017 Financial Results On February 13, 2017

Financials for 3rd Quarter Ended December 31, 2016 will be released on February 9, 2017

Elite Reports On SequestOx™ FDA End-of-Review Meeting

Elite Reports On SequestOx™ FDA End-of-Review Meeting

Elite Will Proceed with Studies Required for an NDA Resubmission

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2017 And Provides Conference Call Information

Elite Pharmaceuticals, Inc. Reports Financial Results For The Second Quarter Of Fiscal Year 2017 And Provides Conference Call Information

Conference Call Scheduled for Thursday, November 10th at 1:30 PM EST

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss 2nd Quarter 2017 Financial Results On November 10, 2016

Elite Pharmaceuticals, Inc. To Host Conference Call To Discuss 2nd Quarter 2017 Financial Results On November 10, 2016

Financials for 2nd Quarter Ended September 30, 2016 will be released on November 9, 2016

Trending Tickers: CZR, APO, MCUR, KS, ELTP

Trending Tickers: CZR, APO, MCUR, KS, ELTP

Caesars shares sink after a judge ruled that it would not be shielded from $11 billion in bondholder lawsuits.

Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2017 And Provides Conference Call Information

Elite Pharmaceuticals, Inc. Reports Financial Results For The First Quarter Of Fiscal Year 2017 And Provides Conference Call Information

Conference Call Scheduled for Thursday, August 11th  at 11:00 AM EDT

Elite Pharmaceuticals Announces Changes To Their Board Of Directors

Elite Pharmaceuticals Announces Changes To Their Board Of Directors

Gene Pfeifer Joins Elite's Board